Epstein-Barr virus associated hemophagocytic lymphohystiocytosis during maintenance treatment of acute lymphoblastic leukemia [3]

Pediatric Blood and Cancer

Volumn 46, Issue 7, 2006, Pages 832-

  Kuzmanovic, Milos ^a,b   Rasovic, Nada ^a   Micic, Dragan ^a   Bunjevacki, Gordana ^a   Pasic, Srdjan ^a  

^a Mother and Child Health Institute Belgrade rs   (Serbia)

^b Mother and Child Health Institute of Serbia Dr Vukan Cupic ^*  (Serbia)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE LYMPHOBLASTIC LEUKEMIA; CASE REPORT; CHILD; DISEASE ASSOCIATION; EPSTEIN BARR VIRUS; HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS; HUMAN; IMMUNE RESPONSE; LETTER; MAINTENANCE THERAPY; MALE; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; REMISSION;

EID: 33646551180     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.20771     Document Type: Letter

References (5)

1. Imashuku S. Clinical features and treatment strategies of Epstein-Barr virus-associated hemphagocytic lymphohistiocytosis. Crit Rev Oncol Hematol 2001;44:259-272.
2. Henter JI, Samuelsson-Horne A, Arico M, et al. Treatment of hemphagocytic lymphohistiocytosis with HLH-94 immunochemotherapy and bone marrow transplantation. Blood 2002;100:2367-2373.
3. Imashuku S, Hibi S, Ohara T, et al. Effective control of Epstein-Barr virus-related hemophagocytic lymphohistiocytosis with immunochemotherapy. Blood 1999;93:1869-1874.
4. Imashuku S, Kuriyama K, Teramura T, et al. Requirement for etoposide in the treatment of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis. J Clin Oncol 2001;19:2665-2673.
5. Janka GE. Modern management of children with hemophagocytic lypmhohistiocytosis. Br J Hematol 2004;124:4-14.